Ketamine for Depression
STUDY BASICS
Are you 18 to 65 years old? Have you been feeling down, low, or depressed? You may be able to participate in a study designed to test how a fast-acting antidepressant affects your thinking, mood, and life experiences. This study involves a one-time intravenous infusion of ketamine, and completing clinical interviews, questionnaires, and computer-based tasks over 5 weeks. Compensation is provided.
IRB: STUDY21110040
- Ketamine plus mindfulness for depressionMEET THE RESEARCHER

Rebecca Price
Rebecca B. Price, PhD, is an Associate Professor of Psychiatry and Psychology at the University of Pittsburgh and director of the Clinical Application of Neuroscience lab. Dr. Price’s research interests center on the role of neurocognitive factors in the etiology, course, and treatment of depression, anxiety, compulsive behaviors, and suicidality. She is particularly interested in the intersection of clinical and neurocognitive research, and translating basic cognitive and affective neuroscience findings into novel brain-based behavioral and biological interventions.